|
A philips employees became aware of an adverse event that occurred on 02 june 2021 where a superior vena cava (svc)/innominate tear occurred.Further information was obtained on 29 september 2021 from the physician¿s operation note.A lead extraction procedure commenced for removal and reimplantation of pacemaker device due to the device eroding through the skin of the patient.A right ventricular (rv), a right atrial (ra), and a left ventricular (lv) lead were to be removed to replace the device.The physician made an incision over the device on the left side of the chest.The device was showing through the skin and the leads were visible.The lv lead, with a dwell time of only two years, was targeted first and was successfully extracted.Spectranetics lead locking devices (lld) were then placed on the rv and ra lead to aid in extraction.Physician utilized 12f spectranetics glidelight laser sheath on the ra lead and began lasing from the subclavian vein through the innominate vein.There were multiple lead-on-lead binding sites, so the physician switched to the rv lead and advanced further down the svc.Once progress was made just past the svc and the ra, both leads appeared to be freed up and simultaneously retracted with simple tension.At this point, the patient¿s blood pressure dropped.There were no signs of effusion on transesophageal echocardiography (tee) and there was concern for an svc tear.The cardiothoracic surgeon immediately performed a sternotomy, and a 3 cm svc/innominate tear was discovered.Patient was given medication and patient¿s blood pressure rose.Repair and reimplantation was successful and patient survived the procedure.This report captures the glidelight device in use when the svc/innominate perforation occurred, requiring intervention.There was no alleged malfunction of any spectranetics devices in use during the procedure.
|